Consensus HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Market Closed - Nyse Other stock markets 04:00:02 2024-04-16 pm EDT			5-day change	1st Jan Change
313.9 ^USD	-2.71%		-4.56%	+15.96%

Apr. 15	Truist Securities Adjusts Price Target on HCA Healthcare to $375 From $345	MT
Apr. 15	Ondine Biomedical's Steriwave reduces SSI's by 32%, study shows	AN

Evolution of the average Target Price on HCA Healthcare, Inc.

Price target over the last 5 years

History of analyst recommendation changes

61d1ad6fa89c72e4e200929c.N-nmFPg8mX02XxJq0tt39sFB2KlkoUB4s79MeBj_ECQ.W9iIW7QE-klvNVwE54kWoIJzksxV8CQS44oiEC2XJXJo2px2y1DcIkAXVw~7a6535ef16af1b31e4027e7d835ce36d

Analyst Recommendations on HCA Healthcare, Inc.

Truist Securities Adjusts Price Target on HCA Healthcare to $375 From $345	Apr. 15	MT
Deutsche Bank Adjusts HCA Healthcare Price Target to $359 From $330, Maintains Buy Rating	Apr. 12	MT
Wells Fargo Raises Price Target on HCA Healthcare to $315 From $303, Maintains Equalweight Rating	Mar. 28	MT
ANALYST RECOMMENDATIONS : Nasdaq, Stellantis, Clorox, Ulta Beauty, Standard Chartered...	Mar. 26
Hca Healthcare Insider Sold Shares Worth $400,057, According to a Recent SEC Filing	Mar. 21	MT
ANALYST RECOMMENDATIONS : Doordash, Microsoft, Roblox, Uber, Redrow...	Feb. 08
UBS Adjusts HCA Healthcare Price Target to $348 From $305, Maintains Buy Rating	Jan. 31	MT
Deutsche Bank Raises HCA Healthcare Price Target to $330 From $280, Maintains Buy Rating	Jan. 31	MT
Raymond James Raises Price Target on HCA Healthcare to $330 From $300, Maintains Outperform Rating	Jan. 31	MT
Oppenheimer Raises HCA Healthcare Price Target to $330 From $315, Maintains Outperform Rating	Jan. 31	MT
RBC Raises Price Target on HCA Healthcare to $322 From $308 Amid 'Impressive' Q4 Results, 2024 Guidance; Outperform Kept	Jan. 31	MT
RBC Raises Price Target on HCA Healthcare to $308 From $284, Keeps Outperform Rating	Jan. 24	MT
Bernstein Downgrades HCA Healthcare to Market Perform From Outperform, Price Target is $301	Jan. 04	MT
Goldman Sachs Downgrades HCA Healthcare to Neutral From Buy, Cuts Price Target to $271 From $281	Dec. 11	MT
Argus Cuts HCA Healthcare Price Target to $290 From $310, Maintains Buy Rating	Dec. 04	MT
JPMorgan Adjusts Price Target on HCA Healthcare to $265 From $313, Maintains Neutral Rating	Nov. 17	MT
ANALYST RECOMMENDATIONS : Best Buy, Diageo, Eli Lilly, Estee Lauder, Home Depot...	Nov. 07
Goldman Sachs Cuts Price Target on HCA Healthcare to $281 From $329, Maintains Buy Rating	23-10-30	MT
Deutsche Bank Cuts HCA Healthcare's Price Target to $280 From $310, Maintains Buy Rating	23-10-26	MT
Wells Fargo Adjusts HCA Healthcare's Price Target to $254 From $267, Keeps Equalweight Rating	23-10-26	MT
Mizuho Adjusts HCA Healthcare's Price Target to $275 From $325, Keeps Buy Rating	23-10-25	MT
Stephens Cuts HCA Healthcare's Price Target to $280 From $310, Keeps Overweight Rating	23-10-25	MT
UBS Adjusts HCA Healthcare Price Target to $305 From $323, Maintains Buy Rating	23-10-25	MT
Raymond James Cuts Price Target on HCA Healthcare to $280 From $320, Maintains Outperform Rating	23-10-25	MT
RBC Cuts Price Target on HCA Healthcare to $284 From $315 After Q3 Adjusted Earnings Miss, Keeps Outperform Rating	23-10-25	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

322.6 USD

Average target price

341.2 USD

Spread / Average Target

+5.75%

High Price Target

378 USD

Spread / Highest target

+17.16%

Low Price Target

285 USD

Spread / Lowest Target

-11.66%

Consensus detail

Consensus revision (last 18 months)

Analysts covering HCA Healthcare, Inc.

Truist Securities
Deutsche Bank Securities
Wells Fargo Securities
UBS
Raymond James
Oppenheimer
RBC Capital Markets
Bernstein
Goldman Sachs
Argus
JPMorgan Chase
Mizuho Securities
Stephens Inc.
Baptista Research
Credit Suisse
Barclays
Jefferies & Co.
Citigroup
BofA Securities
TD Cowen
Loop Capital
Cantor Fitzgerald
Cowen
SVB Securities LLC
BMO Capital
SVB Leerink
Seaport Global Securities

Ratings for HCA Healthcare, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar